DRKS00012917Not yet recruiting未知
Minimum dose of intervention duration with effect on trunk stability and compensation of perturbations conducted within the MiSpEx-Network [National Research Network for Medicine in Spine Exercise]: National research network for diagnosis, prevention and treatment of back pain for elite athletes and the general population - MiSpEx - Intervention Study
Hochschulambulanz der Universität Potsdam0 sites80 target enrollmentStarted: August 22, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 55 Years (—)
- Sex
- All
Inclusion Criteria
- •both gender; aged 18 - 50 years
Exclusion Criteria
- •Acute infection, pregnancy, any illness that contraindicates exercise, as well as acute or chronic back pain
Investigators
Similar Trials
Completed
Not Applicable
Determination of minimum and non-provoking doses of soy protein in soy allergic individualssoy allergy10001708food allergyNL-OMON39595FARRP; Food Allergy Research and Resource Program, Department of Food Science & Technology, University of Nebraska10
Completed
Phase 2
Determination of minimal dose of Lidocaine with Sufentanil‘s fixed dose in spinal anesthesia for cesarean section.Delivery by elective caesarean section.Delivery by elective caesarean sectionIRCT201102071310N7Vice Chancellor for Research Kermanshah University of Medical Sciences126
Withdrawn
Not Applicable
Determination of Minimum and Non-provoking Doses of Soy Protein in Soy Allergic Individualsfood allergysoy allergy10001708NL-OMON34810FARRP: Food Allergy Research and Resource Program5
Not yet recruiting
Not Applicable
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188
Recruiting
Phase 1
Dose finding study for deciding the optimal dose of fluorescein during probe based confocal endomicroscopyJPRN-UMIN000027696ational Cancer Center Hospital24